Back to Rankings

ZYME

ZymeworksD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ZYME vs peer average
34/100
ZYME vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

REGN is the first available peer comparator.

Regeneron — larger biologics platform; useful comparator for platform value realization though scale differs.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerREGNRegeneron
ZYME
Zymeworks
REGN
Regeneron
Grade
D
C
Momentum
38
12
Value
41
66
Sentiment
58
71
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs REGN

ZYME / REGN
Grade Position
Below peers
ZYME vs. peer average (D vs. C)
34/100
Momentum
38
ZYME
Value
41
REGN
Sentiment
58
REGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZYME
1
REGN
REGN
C
60/100
-1
2
MGNX
MGNX
A
100/100
-3
3
ATAI
AtaiBeckley Inc Common
B
80/100
-2
4
STOK
Stoke Therapeutics Inc Common
D
40/100
Even
5
ADMA
ADMA Biologics Inc Common
D
40/100
Even
REGN is the first peer returned for this comparison set.